Biedler et al., “Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture,” Cancer Research, 33, pp. 2643-2652 (Nov. 1973). |
Costa et al., “Drug Efficacy at Guanine Nucleotide-Binding Regulatory Protein-Linked Receptors: Thermodynamic Interpretation of Negative Antagonism and of Receptor Activity in the Absence of Ligand,” Molecular Pharmacology, 41,pp. 549-560 (1992). |
Frey and Kebabian, “A μ-Opiate Receptor in 7315c Tumor Tissue Mediates Inhibition of Immunoreactive Prolactin Release and Adenylate Cyclase Activity,” Endocrinology, 115(5), pp. 1797-1804 (1984). |
Kogan et al., “Elevated Basal Firing Rates and Enhanced Responses to 8-Br-cAMP in Locus Coeruleus Neurons in Brain Slices from Opiate-Dependent Rats,” European Journal of Pharmacology, 211,pp. 47-53 (1992). |
Nestler, Eric J., “Molecular Mechanisms of Drug Addiction,” The Journal of Neuroscience, 12(9), pp. 2439-2450 (Jul. 1992). |
Rasmussen et al., “Opiate Withdrawal and the Rat Locus Coeruleus: Behavioral, Electrophysiological, and Biochemical Correlates,” The Journal of Neuroscience, 10(7), pp. 2308-2317 (Jul. 1990). |
Sibinga and Goldstein, “Opioid Peptides and Opioid Receptors in Cells of the Immune System,” Ann. Rev. Immunolo., 6,pp. 219-249 (1988). |
Yu et al., “A Human Neuroblastoma Cell Line Expresses μand δOpioid Receptor Sites,” The Journal of Biological Chemistry, 261,pp. 1065-1070 (1986). |
Abdelhamid and Takemori, “Characteristics of μand δOpioid Binding Sites in Striatal Slices of Morphine-Tolerant and -dependent Mice,” Journal of Pharmacology, 198,pp. 157-163 (1991). |
Sharma et al., Dual Regulation of Adenylate Cyclase Accounts for Narcotic Dependence and Tolerance, Proc. Nat. Acad. Sci. USA, 72(8), pp. 3092-3096 (Aug. 1975). |
Saée et al., “Constitutive Activation of the μ-Opioid Receptor: A Novel Paradiagm of Receptor Regulation in Narcotic Analgesia, Tolerance, and Dependence,” Analgesia, 1(1), pp. 11-14 (1994). |
Lameh et al., “Agonist Induced Conversion of the Hm1 Muscarinic Cholinergic Receptor to a Constitutively Active State: A Novel Papadign of Receptor Regulation,” p. 57 of the program for Subtypes of Muscarinic Receptors: The 6th International Symposium, sponsored by Boston University School of Medicine and Johann Wolfgang-Goethe University, held in Fort. Lauderdale, Florida, Nov. 9-12, 1994. |
Baker, Mitzi, “New Hypothesis on How Narcotics Produce Tolerance, Dependency,” Synapse(newspaper of the University of California, San Francisco), 39(15), pp. 1 and 5 (Jan. 12, 1995). |
Högger et al., “Activating and Inactivating Mutations in N- and C-terminal i3 Loop Junctions of Muscarinic Acetylcholine Hm1 Receptors,” The Journal of Biological Chemistry, 270(13), pp. 7405-7410 (1995). |
Wang et al., “Agonist Induced Constitutive Activation of the μ Opioid Receptor by Phosphorylation,” Regulatory Peptides, 54(1), pp. 323-324 (1994). |
Yu and Sadée,“Efficacy and Tolerance of Narcotic Analgesics at the Mu Opiod Receptor in Differentiated Human Neuroblastoma Cells,” The Journal of Pharmacology and Experimental Therapeutics, 245(1), pp. 350-355 (1988). |
Yu et al., “Differentiation of Human Neuroblastoma Dells: Marked Potentiation of Prostaglandin E-Stimulated Accumulation of Cyclic AMP by Retinoic Acid,” Journal of Neurochemistry, 51(6), pp. 1892-1899 (1988). |
Yu et al., “Regulation of Cyclic AMP by the μ-Opioid Receptor in Human Neuroblastoma SH-SY5Y Cells,” Journal of Neurochemistry, 55(4), pp. 1390-1396 (1990). |
Schütz and Freissmuth, “Reverse Intrinsic Activity of Antagonists on G Protein-Coupled Receptors,” TiPS, 13,pp. 376-379 (Oct. 1992). |
Chen et al., “Molecular Cloning and Functional Expression of a μ-Opioid Receptor from Rat Brain,” Molecular Pharmacology, 44,pp. 8-12 (1993). |
Wang et al., “Constitutive μ Opioid Receptor Activation as a Regulatory Mechanism Underlying Narcotic Tolerance and Dependence,” Life Sciences, 54(20), pp. 339-350 (1994). |
Smith and Loh, “Problems and Approaches in Studying Membrane Opioid Receptors,” in Molecular Approaches to Drug Abuse Research vol. 1: Receptor Cloning, Neurotransmitter Expression, and Molecular Genetics,ed. Theresa N. H. Lee, pp. 69-84 (1991). |
Hawkins et al., “[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), A Potent and Highly Selective Peptide for Mu Opioid Receptors in Rat Brain,” The Journal of Pharmacology and Experimental Therapeutics, 248(1), pp. 73-80 (1989). |